The most commonly used maintenance dose of allopurinol is 300mg daily, but this dose may not reduce serum urate enough to suppress gout flares. Find out more about appropriate allopurinol dosing in this microlearning.
Chronic hepatitis C can cause cirrhosis, liver failure, cancer and early death. Raising awareness that hep C can be cured with a short course of oral antivirals is vital. Read this microlearning to find out more.
Metered dose inhalers such as salbutamol contain hydrofluorocarbon propellants, powerful greenhouse gases that contribute to global warming. Read this microlearning to find out more about inhaler carbon footprint and environmentally friendly alternatives.
Antimicrobial resistance (AMR) is a global crisis and a growing problem in Aotearoa New Zealand. Read this microlearning to learn how health providers can help slow AMR, and find links to other resources.
Read this microlearning to find out more about the appropriate use and supply of opioids.
Approximately 80% of women experience perimenopause symptoms. Menopausal hormone therapy (MHT) can greatly help to improve symptom severity and frequency. Read this microlearning to find out more.
Benzodiazepines and zopiclone are used frequently and for extended periods to aid sleep, despite well-recognised harms of dependency, cognitive decline and falls. Find out more about benzodiazepine and zopiclone use in Aotearoa in this piece of microlearning.
With coughs and colds doing the rounds, the He Ako Hiringa Virus Action Plans can help manage patient expectations for antibiotics. Read this microlearning to learn more.
Methylphenidate and dexamfetamine are now funded for up to three months’ supply when prescribed through the New Zealand ePrescription Service (NZePS). Read this microlearning to find out more.
Liraglutide (Victoza brand only) joins dulaglutide as a funded GLP-1 receptor agonist for treating type 2 diabetes. This piece of microlearning outlines the differences and similarities between the two medicines.